JD-SW
09618
MEITUAN-W
03690
JD HEALTH
06618
BABA-W
09988
TME-SW
01698
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 4.79%91.66M | ---- | -40.30%87.47M | ---- | 571.77%146.51M | ---- | -75.91%21.81M | ---- | -18.28%90.54M |
Profit adjustment | ||||||||||
Interest expense - adjustment | ---- | 27.80%40.74M | ---- | 24.63%31.88M | ---- | -22.21%25.58M | ---- | -39.16%32.88M | ---- | -1.08%54.05M |
Attributable subsidiary (profit) loss | ---- | -30.71%-2.24M | ---- | ---1.72M | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 4.81%6.89M | ---- | 31.34%6.58M | ---- | 3.11%5.01M | ---- | -24.79%4.86M | ---- | 127.76%6.46M |
-Depreciation | ---- | 4.81%6.89M | ---- | 31.34%6.58M | ---- | 3.11%5.01M | ---- | -24.79%4.86M | ---- | 127.76%6.46M |
Exchange Loss (gain) | ---- | 105.32%60K | ---- | -425.72%-1.13M | ---- | -76.48%346K | ---- | 520.29%1.47M | ---- | 37.72%-350K |
Special items | ---- | ---- | ---- | -609.18%-3.79M | ---- | -306.98%-534K | ---- | 104.60%258K | ---- | -348.18%-5.6M |
Operating profit before the change of operating capital | ---- | 16.19%138.61M | ---- | -32.57%119.29M | ---- | 188.71%176.91M | ---- | -57.77%61.28M | ---- | -14.64%145.09M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | -366.71%-113.4M | ---- | -320.67%-24.3M | ---- | ---5.78M | ---- | ---- | ---- | ---- |
Financial assets at fair value (increase)decrease | ---- | 171.85%13.55M | ---- | 80.27%-18.86M | ---- | -29.21%-95.6M | ---- | -3,414.96%-73.99M | ---- | -110.72%-2.11M |
Derivative financial instruments (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%7.95M | ---- | ---7.95M |
Buy and sell back financial assets (increase) decrease | ---- | ---200.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items for working capital changes | ---- | 81.24%-23.13M | ---- | -305.32%-123.29M | ---- | -86.96%60.05M | ---- | 508.22%460.49M | ---- | -196.15%-112.8M |
Cash from business operations | -312.23%-159.77M | -291.03%-184.39M | 518.53%75.28M | -134.78%-47.15M | 113.47%12.17M | -70.25%135.58M | -120.20%-90.35M | 1,950.40%455.72M | 616.19%447.28M | -92.76%22.23M |
Other taxs | -2.05%-22.82M | -8.82%-31.38M | -6.58%-22.36M | -68.94%-28.84M | -121.46%-20.98M | 40.62%-17.07M | 60.69%-9.48M | 14.64%-28.75M | 12.35%-24.1M | -89.27%-33.68M |
Interest received - operating | -88.67%513K | -47.97%2.26M | 4.35%4.53M | -13.53%4.34M | -13.53%4.34M | -71.08%5.02M | -77.08%5.02M | 42.53%17.35M | 79.88%21.9M | 76.31%12.17M |
Interest paid - operating | -105.42%-25.91M | -31.90%-40.68M | 12.86%-12.61M | -23.03%-30.84M | -17.72%-14.48M | 25.28%-25.07M | 36.61%-12.3M | 37.61%-33.55M | 36.51%-19.4M | 15.70%-53.77M |
Net cash from operations | -563.91%-207.99M | -148.01%-254.19M | 336.63%44.83M | -204.10%-102.49M | 82.31%-18.95M | -76.03%98.46M | -125.16%-107.1M | 874.43%410.78M | 421.20%425.68M | -122.84%-53.04M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | 30.71%2.24M | --2.13M | --1.72M | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --88K | ---- |
Purchase of fixed assets | -89.03%-2.02M | 23.16%-7.26M | 83.15%-1.07M | 67.28%-9.45M | -1,310.69%-6.33M | -180,337.50%-28.87M | ---449K | 96.60%-16K | ---- | 56.12%-470K |
Purchase of intangible assets | ---- | 69.31%-31K | 69.31%-31K | -29.49%-101K | -55.38%-101K | 85.47%-78K | 86.46%-65K | -4.68%-537K | ---480K | 98.63%-513K |
Acquisition of subsidiaries | ---- | ---- | ---- | 11.05%-14.21M | -33.17%-13.49M | ---15.98M | ---10.13M | ---- | ---- | -344.46%-20.45M |
Recovery of cash from investments | -68.32%8.23M | 236.81%19.13M | --25.97M | --5.68M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | 81.33%-2.44M | 5.49%-9.29M | -87.10%-13.06M | 68.03%-9.83M | 60.59%-6.98M | -358.48%-30.75M | -811.32%-17.72M | ---6.71M | ---1.94M | ---- |
Net cash from investment operations | -72.95%3.77M | 118.32%4.8M | 151.82%13.94M | 65.39%-26.19M | 5.12%-26.91M | -942.42%-75.67M | -1,114.04%-28.36M | 66.14%-7.26M | 90.94%-2.34M | 50.90%-21.44M |
Net cash before financing | -447.45%-204.22M | -93.81%-249.39M | 228.18%58.78M | -664.63%-128.68M | 66.15%-45.85M | -94.35%22.79M | -132.00%-135.46M | 641.79%403.52M | 367.40%423.34M | -139.49%-74.48M |
Cash flow from financing activities | ||||||||||
New borrowing | 78.22%698.89M | 6.09%1.13B | -31.55%392.15M | 49.77%1.07B | 14.81%572.92M | -44.82%712.51M | -41.40%499M | -10.39%1.29B | -31.95%851.55M | 31.81%1.44B |
Refund | -9.73%-474.05M | 0.78%-927M | 17.71%-432M | -43.22%-934.3M | -46.10%-525M | 62.74%-652.35M | 73.52%-359.34M | -34.53%-1.75B | -30.31%-1.36B | 6.02%-1.3B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | 136.98%1.32M | --1K | --557K | ---- | ---- |
Dividends paid - financing | -154.95%-35.06M | 12.89%-43.88M | 71.86%-13.75M | -402.08%-50.37M | -387.08%-48.87M | 62.67%-10.03M | 61.42%-10.03M | -7.43%-26.88M | -3.95%-26M | -15.89%-25.02M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40M | --11M |
Other items of the financing business | -96.88%1M | 217.65%32.4M | 3,466.67%32.1M | -83.35%10.2M | 118.00%900K | 512.50%61.25M | 83.33%-5M | --10M | ---30M | ---- |
Net cash from financing operations | 928.12%189.44M | 112.02%189.92M | -1,535.17%-22.88M | -17.38%89.58M | -101.14%-1.4M | 122.63%108.42M | 123.45%122.66M | -494.60%-479.17M | -386.82%-523.01M | 138.75%121.43M |
Effect of rate | -593.40%-523K | -105.32%-60K | -88.65%106K | 425.72%1.13M | 495.76%934K | 76.48%-346K | 13.55%-236K | -520.29%-1.47M | -202.63%-273K | -37.72%350K |
Net Cash | -141.16%-14.78M | -52.09%-59.47M | 175.97%35.9M | -129.80%-39.1M | -269.16%-47.25M | 273.45%131.21M | 87.16%-12.8M | -261.12%-75.65M | -514.78%-99.67M | 137.64%46.95M |
Begining period cash | -30.25%137.27M | -16.18%196.81M | -16.18%196.81M | 125.93%234.78M | 125.93%234.78M | -42.60%103.92M | -42.60%103.92M | 35.37%181.04M | 35.37%181.04M | -48.15%133.74M |
Cash at the end | -47.61%121.97M | -30.25%137.27M | 23.53%232.81M | -16.18%196.81M | 107.37%188.46M | 125.93%234.78M | 12.07%90.88M | -42.60%103.92M | -48.68%81.1M | 35.37%181.04M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Rosenmei Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Unlock the Full List